Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A proteolytic system that compensates for loss of proteasome function

R Glas1, M Bogyo, J S McMaster

  • 1Center for Cancer Research, Department for Biology, Massachusetts Institute of Technology, Cambridge 02139-4307, USA.

Nature
|April 29, 1998
PubMed
Summary

In mammalian cells, inhibiting the proteasome leads to resistant cell growth. This adaptation is supported by alternative proteolytic systems compensating for lost proteasome function.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tetra-anionic porphyrin mimics protein-protein interactions between regulatory particles and the catalytic core, allosterically activating human 20S proteasome.

Journal of enzyme inhibition and medicinal chemistry·2025
Same author

Fluorescence Imaging for Cancer Screening and Surveillance.

Molecular imaging and biology·2017
Same author

Erratum to: Purinergic P2X7 receptors regulate secretion of interleukin-1 receptor antagonist and beta cell function and survival.

Diabetologia·2015
Same author

Loss of Prkar1a leads to Bcl-2 family protein induction and cachexia in mice.

Cell death and differentiation·2014
Same author

Serine proteases and protease-activated receptor 2 mediate the proinflammatory and algesic actions of diverse stimulants.

British journal of pharmacology·2014
Same author

Cathepsin X is activated by cathepsin L, inactivates the chemokine SDF-1 and reduces adhesion of hematopoietic stem and progenitor cells to osteoblasts.

Journal of stem cells & regenerative medicine·2014

Area of Science:

  • Cellular biology
  • Biochemistry
  • Molecular biology

Background:

  • Proteolysis is a fundamental cellular process crucial for protein homeostasis and cellular signaling.
  • The proteasome is a key multi-subunit protease complex responsible for regulated protein degradation.
  • Dysfunctional proteasomes are implicated in various diseases, making them therapeutic targets.

Purpose of the Study:

  • To investigate the cellular response to proteasome inhibition in mammalian cells.
  • To identify mechanisms of resistance that emerge following proteasome inactivation.
  • To explore the role of alternative proteolytic systems in cell survival under proteasome-impaired conditions.

Main Methods:

  • Treatment of mammalian cells with covalent proteasome inhibitors.

Related Experiment Videos

  • Monitoring cell viability and outgrowth of inhibitor-resistant populations.
  • Analysis of gene expression and protein activity to identify compensatory mechanisms.

    • Main Results:

    • Inactivation of the proteasome by covalent inhibitors resulted in the outgrowth of inhibitor-resistant cells.
    • Adapted cells demonstrated enhanced survival despite the loss of proteasomal activity.
    • Evidence suggests the induction of alternative proteolytic pathways in these resistant cells.

    Conclusions:

    • Mammalian cells can develop resistance to proteasome inhibitors through adaptation.
    • Alternative proteolytic systems play a critical role in compensating for proteasome dysfunction.
    • Understanding these compensatory mechanisms is vital for developing effective proteasome-targeted therapies.